Asia Pacific Medical Equipment Market Outlook to 2030: Size, Share, Growth and Trends

The Asia Pacific Medical Equipment Market is valued at USD 133,570 Mn in 2024, and 2024 is the base year for the report. The market is measured at manufacturer and distributor revenue level, using ex-factory sales plus import CIF values, net of intra-channel transfers. That lens matters because it reflects monetized industry revenue rather than hospital spend or patient outlay. The market also carries substantial scale in physical throughput, with about 2,210 million units or device-equivalents in 2024, which shows that lower-ticket devices and consumables-linked systems materially widen the addressable pool beyond large capital equipment alone.

The Asia Pacific Medical Equipment Market is projected to reach USD 212,700 Mn by 2030, implying a forecast CAGR of 8.1% across 2025-2030. This is a step-up from the modeled historical CAGR of 7.4% during 2019-2024, showing that the market has moved beyond post-pandemic normalization into a structurally stronger expansion phase. Growth is not purely unit-led. Volume is expected to rise to about 3,250 million units by 2030, but revenue grows faster than volume because mix shifts toward implants, digital health, higher-spec diagnostics, and service-linked systems that carry stronger realized pricing.

The profit pool is gradually shifting toward digitally enabled, monitoring-rich, and software-connected categories. In 2024, Wearable & Digital Health Devices represented 10.3% of market value, and this segment is the fastest-growing at 16.4% CAGR. By contrast, Diagnostic Imaging Equipment remains large but grows more slowly at 6.3% CAGR, reflecting capital budgeting discipline and replacement-led demand. This means the market’s best economics increasingly sit where hardware is bundled with analytics, remote monitoring, data management, or recurring consumables rather than in stand-alone big-ticket equipment sales alone.

The largest structural risk is uneven affordability and installed-base depth across countries. In advanced markets, equipment density is already high, while in lower-income markets financing constraints still distort adoption. Japan reports 57 MRI units per million population, but several Asia Pacific markets still have fewer than 1 unit per million. At the same time, low- and lower-middle-income Asia Pacific markets still fund 43.1% of health spending out-of-pocket. That combination slows premium device penetration, limits replacement cycles, and forces suppliers to manage a wider spread of product tiers, clinical evidence demands, and reimbursement realities.

China is the largest single-country market within the Asia Pacific Medical Equipment Market peer set. The modeled 2024 country split places China at about USD 46,600 Mn, ahead of Japan at USD 29,000 Mn and India at USD 17,900 Mn. China’s scale advantage comes from a combination of manufacturing density, hospital infrastructure, and policy-led localization. It also offers stronger medium-term momentum than mature peers such as Japan and Australia, with a projected CAGR of 8.4%. India grows faster percentage-wise, but from a much smaller spending and installed-base starting point.

The core demand engine is the interaction of chronic disease burden, ageing, and expanding public health financing. Western Pacific countries recorded 12 million NCD deaths in 2019, and the WHO South-East Asia Region reports 8.5 million annual NCD deaths. That disease profile drives sustained need for cardiology devices, IVD, imaging, surgical tools, and patient monitoring. Demand is reinforced by demographic ageing; in lower- and lower-middle-income Asia Pacific, the population aged 65+ is projected to rise from 6% in 2023 to 13% in 2050. These shifts lengthen the structural runway for chronic-care and multi-modality device deployment.